Blaise A Coleman
Chief Executive Officer chez ENDO INTERNATIONAL PLC
Fortune : 169 $ au 31/03/2024
Profil
Blaise A Coleman is currently the President, Chief Executive Officer & Director at Endo International Plc.
Previously, he held positions as the Chairman, President & Chief Executive Officer at BioSpecifics Technologies Corp.
and as the Senior Director-Commercial Finance at AstraZeneca US Investments Ltd.
He also served as the Chief Financial Officer at AstraZeneca AB from 2013 to 2015.
Mr. Coleman completed his undergraduate degree at Widener University and earned an MBA from The Fuqua School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ENDO INTERNATIONAL PLC
0,18% | 12/04/2023 | 422 066 ( 0,18% ) | 169 $ | 31/03/2024 |
Postes actifs de Blaise A Coleman
| Sociétés | Poste | Début |
|---|---|---|
| ENDO INTERNATIONAL PLC | Chief Executive Officer | 06/03/2020 |
| AUXILIUM PHARMACEUTICALS, INC. | Director/Board Member | - |
| Endo Innovation Valera LLC | Director/Board Member | - |
Generics International (US), Inc.
 Generics International (US), Inc. Pharmaceuticals: MajorHealth Technology Founded in 1983, Qualitest provides affordable, high-quality generic pharmaceuticals. Featuring a current portfolio exceeding 600 products, the company has grown significantly since its inception and is now ranked in the top ten among all suppliers of generics, based on total prescriptions filled. Privately held, Qualitest has its headquarters and distribution facilities in Huntsville, Alabama, with a workforce of over 600 employees. | Chairman | - |
Innoteq, Inc.
 Innoteq, Inc. Pharmaceuticals: MajorHealth Technology Part of Endo International Plc, Innoteq, Inc. produces pharmaceutical and other consumer products. The private company is based in Stratford, CT. Innoteq was acquired by Endo Generics Holdings, Inc., part of Endo International Plc from September 28, 2015 on January 09, 2015 for $26.40 million. | Chairman | - |
Par Pharmaceutical, Inc.
 Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Par Pharmaceutical, Inc. manufactures and markets generic drugs and pharmaceuticals products. It produces drugs for hypertension, inflammation, depression and pain. The firm distributes its products in the semi-solid form of a cream. The company was founded in 1978 and is headquartered in Chestnut Ridge, NY. | Chairman | - |
Par Pharmaceutical Cos., Inc. (New Jersey)
 Par Pharmaceutical Cos., Inc. (New Jersey) Pharmaceuticals: MajorHealth Technology Part of Endo International Plc, Par Pharmaceutical Cos., Inc. is a pharmaceutical company based in Woodcliff Lake, NJ. The private company manufactures and sells pharmaceutical products. | Chairman | - |
Par Pharmaceutical Holdings, Inc.
 Par Pharmaceutical Holdings, Inc. MiscellaneousMiscellaneous Par Pharmaceutical Holdings, Inc. operates as a holding company that engages in the development, license, manufacture, market, and distribution of generic drugs. The company was founded on July 12, 2012 and is headquartered in New York. | Chairman | - |
Par Sterile Products LLC
 Par Sterile Products LLC Pharmaceuticals: GenericHealth Technology Par Sterile Products LLC engages in the development, manufacturing, and distribution of generic pharmaceuticals. Its products include adrenalin injection, adrenalin chloride solution, aplisol, argatroban injection, brevital sodium, buprenorphine HCL injection, CIII, colistimethate for injection, USP, coly-mycin m, dantrium IV, dantrium capsules, delestrogen, dexmedetomidine HCI, injection, ethacrynate sodium for injection, USP, fluphenazine decanoate injection, USP, ketalar, pitocin, tigan, triostat, vasostrict, and zoledronic acid injection. The company was founded in 2007 and is headquartered in Chestnut Ridge, NY. | Director/Board Member | - |
| ░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Anciens postes connus de Blaise A Coleman
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
| ░░░░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Blaise A Coleman
| Widener University | Undergraduate Degree |
| The Fuqua School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ENDO INTERNATIONAL PLC | Health Technology |
| Entreprise privées | 13 |
|---|---|
BioSpecifics Technologies Corp.
 BioSpecifics Technologies Corp. Pharmaceuticals: MajorHealth Technology BioSpecifics Technologies Corp. engages in the development of an injectable collagenase clostridium histolyticum for multiple indications. It sells its products under the brand XIAFLEX. The company was founded in 1990 and is headquartered in Lynbrook, NY. | Health Technology |
Auxilium Pharmaceuticals LLC
 Auxilium Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Auxilium Pharmaceuticals LLC develops and markets pharmaceutical products. It specializes in men's healthcare area and has product portfolio and pipeline in orthopedics, dermatology and other therapeutic areas. The firm products include edex, Osbon, ErecAid, STENDRA, TESTOPEL, XIAFLEX and Testim. The company was founded by Gerri A. Henwood and Jane Holmes Hollingsworth in 1999 and is headquartered in Chesterbrook, PA. | Health Technology |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
Par Pharmaceutical, Inc.
Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Par Pharmaceutical, Inc. manufactures and markets generic drugs and pharmaceuticals products. It produces drugs for hypertension, inflammation, depression and pain. The firm distributes its products in the semi-solid form of a cream. The company was founded in 1978 and is headquartered in Chestnut Ridge, NY. | Health Technology |
Generics International (US), Inc.
Generics International (US), Inc. Pharmaceuticals: MajorHealth Technology Founded in 1983, Qualitest provides affordable, high-quality generic pharmaceuticals. Featuring a current portfolio exceeding 600 products, the company has grown significantly since its inception and is now ranked in the top ten among all suppliers of generics, based on total prescriptions filled. Privately held, Qualitest has its headquarters and distribution facilities in Huntsville, Alabama, with a workforce of over 600 employees. | Health Technology |
Par Sterile Products LLC
Par Sterile Products LLC Pharmaceuticals: GenericHealth Technology Par Sterile Products LLC engages in the development, manufacturing, and distribution of generic pharmaceuticals. Its products include adrenalin injection, adrenalin chloride solution, aplisol, argatroban injection, brevital sodium, buprenorphine HCL injection, CIII, colistimethate for injection, USP, coly-mycin m, dantrium IV, dantrium capsules, delestrogen, dexmedetomidine HCI, injection, ethacrynate sodium for injection, USP, fluphenazine decanoate injection, USP, ketalar, pitocin, tigan, triostat, vasostrict, and zoledronic acid injection. The company was founded in 2007 and is headquartered in Chestnut Ridge, NY. | Health Technology |
AstraZeneca US Investments Ltd.
 AstraZeneca US Investments Ltd. Financial ConglomeratesFinance Part of AstraZeneca PLC, AstraZeneca US Investments Ltd. functions as an investment holding British company. The private company is based in Cambridge, UK and was founded in 2002. | Finance |
Par Pharmaceutical Holdings, Inc.
Par Pharmaceutical Holdings, Inc. MiscellaneousMiscellaneous Par Pharmaceutical Holdings, Inc. operates as a holding company that engages in the development, license, manufacture, market, and distribution of generic drugs. The company was founded on July 12, 2012 and is headquartered in New York. | Miscellaneous |
Innoteq, Inc.
Innoteq, Inc. Pharmaceuticals: MajorHealth Technology Part of Endo International Plc, Innoteq, Inc. produces pharmaceutical and other consumer products. The private company is based in Stratford, CT. Innoteq was acquired by Endo Generics Holdings, Inc., part of Endo International Plc from September 28, 2015 on January 09, 2015 for $26.40 million. | Health Technology |
Par Pharmaceutical Cos., Inc. (New Jersey)
Par Pharmaceutical Cos., Inc. (New Jersey) Pharmaceuticals: MajorHealth Technology Part of Endo International Plc, Par Pharmaceutical Cos., Inc. is a pharmaceutical company based in Woodcliff Lake, NJ. The private company manufactures and sells pharmaceutical products. | Health Technology |
| Slate Pharmaceuticals LLC | |
| Endo Innovation Valera LLC | |
Vintage Pharmaceuticals LLC
 Vintage Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vintage Pharmaceuticals, Inc. distributes and manufactures generic pharmaceuticals. Its products include tablets, capsules, liquids, suspensions, suppositories, creams, and ointments. The company was founded by William S. Propst in 1983 and is headquartered in Huntsville, AL | Health Technology |
